 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || ZSP1602 / Guangdong Zhongsheng Pharma
Trial completion date, Trial primary completion date, Metastases: A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors (clinicaltrials.gov) - Jul 22, 2020
P1, N=65, Recruiting, Sponsor: Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Trial completion date: Dec 2020 --> Jul 2021 | Trial primary completion date: Nov 2020 --> Jul 2021
- ||| ZSP1602 / Guangdong Zhongsheng Pharma
Enrollment open, Metastases: A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors (clinicaltrials.gov) - Feb 19, 2019
P1, N=65, Recruiting, Sponsor: Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Trial completion date: Dec 2020 --> Jul 2021 | Trial primary completion date: Nov 2020 --> Jul 2021 Not yet recruiting --> Recruiting
- | ZSP1602 / Guangdong Zhongsheng Pharma
New P1 trial, Metastases: A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors (clinicaltrials.gov) - Nov 8, 2018
P1, N=65, Not yet recruiting, Sponsor: Guangdong Zhongsheng Pharmaceutical Co., Ltd.